Interventions for valvular disease and heart failure

TAVR-in-TAVR and coronary access: importance of preprocedural planning

EuroIntervention 2020;16:e129-e132. DOI: 10.4244/EIJ-D-19-01094

Giuseppe Tarantini
Giuseppe Tarantini1, MD, PhD; Tommaso Fabris1, MD; Luca Nai Fovino1, MD, PhD
1. Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy


Introduction

Transcatheter heart valve (THV) degeneration will become increasingly common with the expansion of the indication for transcatheter aortic valve replacement (TAVR) to low-risk younger subjects with longer life expectancy1. Treatment of structural THV degeneration with the implantation of a second THV is feasible, but data on this subject are scant. In particular, there are concerns about the risk of coronary artery obstruction and the possibility of accessing the coronary ostia in case percutaneous coronary artery intervention should be needed in the future2,3,4.

It is crucial to understand the three-dimensional interaction among degenerated THV, coronary ostia and ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Coronary interventionsInterventions for valvular diseaseOther coronary interventionsTAVI
Read next article
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial

Latest news